Top compounds associated with response to ACTL9


Feature Type Standardized
Nominal ANOVA
mRNA Panobinostat CCLE pan-cancer AAC -0.094 0.02
mRNA Erlotinib gCSI pan-cancer AAC -0.13 0.02
mRNA CEP-701 GDSC1000 pan-cancer AAC -0.075 0.02
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.09 0.03
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.07 0.03
mRNA FQI-1 CTRPv2 pan-cancer AAC 0.099 0.03
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.074 0.03
mRNA FMK GDSC1000 pan-cancer AAC 0.079 0.03
mRNA COL-3 CTRPv2 pan-cancer AAC -0.075 0.04
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.067 0.04
Download CSV